Gantacurium

HCID 10102486CAS 758669-50-0

기본 정보

표준 SMILES
COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[N@@+](C)(CCCOC(=O)/C=C(\Cl)C(=O)OCCC[N@+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2
InChIKey
ZQLDXCSTJFLRPY-RWBXLJKRSA-N
분자식
C53H69ClN2O14+2
평균 분자량
993.6 g/mol
단동위원소 질량
992.44263541

개요

Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.

이름 및 식별자

우선 이름
Gantacurium
IUPAC
4-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate

이름 및 동의어

GantacuriumGantacurium ionGantacurium cationN9VK9ZO25E758669-50-0DTXSID902267724-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate4-O-(3-((1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propyl) 1-O-(3-((1R,2S)-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl)propyl) (Z)-2-chlorobut-2-enedioateRefChem:142620DTXCID20149263UNII-N9VK9ZO25ESCHEMBL2606283
이름 더 보기
CHEMBL1182997SCHEMBL29385798ZQLDXCSTJFLRPY-RWBXLJKRSA-NDB05710NS00073673Q27284755(1R,2S)-2-(3-{[(2Z)-2-Chloro-4-{3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydroisoquinolin-2-ium-2(1H)-yl]propoxy}-4-oxobut-2-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium

데이터베이스 식별자

CAS
758669-50-0
PubChem CID
10102486
DTXSID
DTXSID90226772
ChEMBL
CHEMBL1182997
UNII
N9VK9ZO25E
Nikkaji
J1.345.757C、J2.460.188I

물성

구조 계산 물성

XLogP
8.3
극성 표면적
145 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
14
회전 가능 결합 수
25
무거운 원자 수
70

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15

화학 및 산업

약리 정보

Pharmacodynamics · 1건

Gantacurium chloride administered to anesthetized and ventilated healthy volunteers, caused dose dependent transient decrease in arterial blood pressure, mild histamine release at higher doses and no consistent changes in pulmonary compliance.

Biological Half-Life3.09±0.21 minutes
Metabolism/MetabolitesThe pharmacokinetic parameters are consistent with in situ rapid inactivation by plasma cysteine.

관련 반응

1건

연결된 노트

불러오는 중…